Legal Opinion
I-Mab Biopharma v. Inhibrx, Inc.
District Court, D. Delaware
Decided October 21, 2024No. 1:22-cv-00276Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE I-MAB BIOPHARMA, ) ) Plaintiff, ) ) v. ) Civil Action No. 22-276-CJB ) INHIBRX, INC. and BRENDAN ) ECKELMAN, ) ) Defendants. ) MEMORANDUM ORDER In this case, Plaintiff I-Mab Biopharma (“I-Mab” or “Plaintiff”) brings trade secret misappropriation claims against Defendants Inhibrx, Inc. (“Inhibrx”) and Brendan Eckelman (“Dr. Eckelman” and collectively with Inhibrx, “Defendants”). Presently pending before the Court is Plaintiff’s motion to exclude certain opinions offered by Defendants’ technical expert Dr. Roland Newman (the…
2Cases cited4 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- In re: Avandia Marketing v.Court of Appeals for the Third Circuit · 2019
- PPG Industries Inc v. Jiangsu Tie Mao Glass Co LtdCourt of Appeals for the Third Circuit · 2022
- Iconics, Inc. v. MassaroDistrict Court, D. Massachusetts · 2017